Clinical characteristics of Graves' orbitopathy in patients showing discrepancy between levels from TBII assays and TSI bioassay.
about
Bioassays for TSH Receptor Autoantibodies, from FRTL-5 Cells to TSH Receptor-LH/CG Receptor Chimeras: The Contribution of Leonard D. KohnClinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.Development of Thyroid-Associated Ophthalmopathy in Patients Who Underwent Total Thyroidectomy.
P2860
Clinical characteristics of Graves' orbitopathy in patients showing discrepancy between levels from TBII assays and TSI bioassay.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Clinical characteristics of Gr ...... TBII assays and TSI bioassay.
@en
Clinical characteristics of Gr ...... TBII assays and TSI bioassay.
@nl
type
label
Clinical characteristics of Gr ...... TBII assays and TSI bioassay.
@en
Clinical characteristics of Gr ...... TBII assays and TSI bioassay.
@nl
prefLabel
Clinical characteristics of Gr ...... TBII assays and TSI bioassay.
@en
Clinical characteristics of Gr ...... TBII assays and TSI bioassay.
@nl
P2860
P50
P356
P1476
Clinical characteristics of Gr ...... TBII assays and TSI bioassay.
@en
P2093
Sun Young Jang
P2860
P304
P356
10.1111/CEN.12318
P577
2013-09-30T00:00:00Z